Nuvation Bio Inc. (NUVB) Tops Q4 EPS by 4c

Nuvation Bio Inc. (NYSE: NUVB) reported Q4 EPS of ($0.06), $0.04 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
• Barclays Reiterates Overweight Rating on SK Hynix (SKHY)
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance